SCOPE 2021 ATTRACTS MORE THAN 1,500 PARTICIPANTS VIRTUALLY
Now in its 12th year, SCOPE Summit was attended by over 1,500 participants virtually. The impressive executive audience at SCOPE came together for invaluable networking opportunities for four days, with more than 53% of the attendees titled
as a decision-maker from leading Pharma (27%), Biotech companies (22%) and, CRO (26%). Industry leaders and key decision-makers representing more than 500 unique organizations shared case studies, collaborated on best practices, and provided
unique perspectives on poignant issues that the field currently faces.
The 2020 program offered 20 distinct conferences, and three plenary keynote sessions, focused on advances and innovative solutions in all aspects of clinical trial planning, management and operations, including Site Selection and Management,
Participant Engagement, Patient Recruitment and Retention, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Sensors, Wearables, and Clinical Biomarkers, Risk-Based Monitoring, Post-Marketing Studies, Artificial
Intelligence, Medical Devices, Observational Research, China Clinical Development, Clinical Supply Management, as well as COVID-19.
Hear what a few people had to say about SCOPE Summit Virtual 2021
It was so great to hear firsthand what so many organizations are doing to make sure the patient voice is heard throughout their clinical journey, not just in the planning but the execution as well. Thank you!
-Phyllis K., Senior Manager, Events and Community Engagement. Center for Information & Study on Clinical Research Participation (CISCRP)
“This is my second year attending Scope, despite having to be completely virtual it has been an incredible learning experience and I hope to return in the coming years”
-James K., Clinical Trial Specialist, Alnylam Pharmaceuticals
Mark your calendar for 2022
13th Annual SCOPE Summit 2022
February 7-10 | Rosen Shingle Creek
Orlando, Florida
2021 Attendee Profile
SCOPE 2021 ATTRACTS MORE THAN 1,500 PARTICIPANTS VIRTUALLY
The impressive executive audience at SCOPE came together for invaluable networking opportunities with more than 53% of the attendees titled as a decision-maker from leading Pharma (18%), Biotech companies (19%) and, CRO (36%). Industry leaders and key decision-makers representing 28 different countries and more than 770 unique organizations shared case studies, collaborated on best practices, and provided unique perspectives on poignant issues that the field currently faces.